NCT01955733 - Safety and Efficacy of BI 695500 in Patients With Moderately to Severely Active Rheumatoid Arthritis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

November 18, 2015

Study Completion Date

November 7, 2016

Conditions

Arthritis, Rheumatoid

Interventions

DRUG

BI 695500

Trial Locations (43)

Unknown

1301.4.5585 Boehringer Ingelheim Investigational Site, Birmingham

1301.4.5727 Boehringer Ingelheim Investigational Site, Glendale

1301.4.5725 Boehringer Ingelheim Investigational Site, Phoenix

1301.4.5761 Boehringer Ingelheim Investigational Site, Little Rock

1301.4.5765 Boehringer Ingelheim Investigational Site, El Cajon

1301.4.5553 Boehringer Ingelheim Investigational Site, Lakewood

1301.4.5527 Boehringer Ingelheim Investigational Site, Long Beach

1301.4.5771 Boehringer Ingelheim Investigational Site, San Diego

1301.4.5797 Boehringer Ingelheim Investigational Site, Santa Maria

1301.4.5807 Boehringer Ingelheim Investigational Site, Upland

1301.4.5809 Boehringer Ingelheim Investigational Site, Pembroke Pines

1301.4.5567 Boehringer Ingelheim Investigational Site, Tampa

1301.4.5561 Boehringer Ingelheim Investigational Site, Chicago

1301.4.5721 Boehringer Ingelheim Investigational Site, Columbia

1301.4.5811 Boehringer Ingelheim Investigational Site, Cumberland

1301.4.5507 Boehringer Ingelheim Investigational Site, Worcester

1301.4.5715 Boehringer Ingelheim Investigational Site, Grand Rapids

1301.4.5787 Boehringer Ingelheim Investigational Site, Omaha

1301.4.5525 Boehringer Ingelheim Investigational Site, Toms River

1301.4.5779 Boehringer Ingelheim Investigational Site, Brooklyn

1301.4.5717 Boehringer Ingelheim Investigational Site, Charlotte

1301.4.5801 Boehringer Ingelheim Investigational Site, Dayton

1301.4.5549 Boehringer Ingelheim Investigational Site, Memphis

1301.4.5729 Boehringer Ingelheim Investigational Site, Nashville

1301.4.5757 Boehringer Ingelheim Investigational Site, Carrollton

1301.4.5789 Boehringer Ingelheim Investigational Site, Corpus Christi

1301.4.5705 Boehringer Ingelheim Investigational Site, Houston

1301.4.5597 Boehringer Ingelheim Investigational Site, McKinney

1301.4.5795 Boehringer Ingelheim Investigational Site, Beckley

1301.4.0303 Boehringer Ingelheim Investigational Site, Kortrijk

1301.4.0609 Boehringer Ingelheim Investigational Site, Plovdiv

1301.4.1705 Boehringer Ingelheim Investigational Site, Magdeburg

1301.4.1807 Boehringer Ingelheim Investigational Site, Athens

1301.4.3305 Boehringer Ingelheim Investigational Site, Sneek

1301.4.3909 Boehringer Ingelheim Investigational Site, Bialystok

1301.4.3907 Boehringer Ingelheim Investigational Site, Bydgoszcz

1301.4.3915 Boehringer Ingelheim Investigational Site, Krakow

1301.4.3919 Boehringer Ingelheim Investigational Site, Warsaw

1301.4.3917 Boehringer Ingelheim Investigational Site, Wroclaw

1301.4.4013 Boehringer Ingelheim Investigational Site, Amadora

1301.4.4007 Boehringer Ingelheim Investigational Site, Lisbon

1301.4.4809 Boehringer Ingelheim Investigational Site, Seville

1301.4.4813 Boehringer Ingelheim Investigational Site, Seville